Drug-maker Valeant eyes small and large M&A deals

Thu Oct 31, 2013 9:17am EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

Oct 31 (Reuters) - Canada's Valeant Pharmaceuticals International Inc said on Thursday that it sees small, cash-based acquisitions likely in the near term, but is also interested in a "merger of equals" involving a swap of equity.

Chief Executive Michael Pearson said he thinks such a merger will happen, but is unsure of the timing.